Loading stock…

Hinge Health, Inc. (HNGE) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Hinge Health, Inc.

HNGEMarket cap $7.91BPrice $98.0

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Delivers digital physical therapy and chronic pain management through wearable sensors and virtual coaching, cutting the need for costly in-person visits. Employers and insurers use it to slash musculoskeletal care costs, which drain over $600 billion from the US healthcare system yearly.

In Bastion Portfolios?

52W Return+99%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)na–

Revenue Forecast

Rev CAGR (1y)+46%10

Rev CAGR (3y)+31%10

Rev CAGR (5y)+28%10

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+28%8

EPS Growth Y+3+40%9

Quality

Margins

EBIT Margin13%5

Net Income Margin15%7

Free Cash Flow Margin40%10

Debt

Net Debt/EBITDA-4.710

Efficiency

ROE41%10

ROA14%9

Earnings Stability22

GEAR+STRONG76

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)362

P/E Ratio (Forward 3y)222

P/BV23.01

EV Multiples

EV/EBITDA Fwd301

EV/EBIT Fwd312

Yield

Free Cash Flow Yield3.7%5

Dividend Yieldna–

Momentum

Short term

1 month return+7%10

3 month return+9%8

YTD return+111%10

Mid term

Price vs 52wHigh98%10

1 year return+95%10

Long term

3 year return+161%9

5 year return+161%8

Risk Shield

Price Risk

Beta1.71

Volatility53%3

Free Cash Flow

Free Cash Flow Margin40%10

Free Cash Flow Yield3.7%5

Quality

ROCE26%9

Earnings Stability22

Net Debt/EBITDA-4.710

02Growth

Is it actually growing, and how fast?

HNGEHinge Health

Revenue FY25$588M

GROWTH RATING↗

VERY STRONG88 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGRna–

Revenue, next 1Y+46%10

Revenue, next 3Y, CAGR+31%10

Revenue, next 5Y, CAGR+28%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+28%8

EPS growth, FY28E+40%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 88% of companies worldwide.

Revenue is set to grow 31%/yr over the next 3 years, ahead of most of the market.10/10

Revenue held flat over the last 3 years and is set to grow 31%/yr from here.

The runway holds up: revenue is set to grow 28%/yr over five years.10/10

Earnings are set to grow in step with sales (EPS about 28%/yr vs revenue 31%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG98 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+7%10

3-month return+9%8

YTD return+111%10

MID & LONG-TERM▾SCORE

% of 52-week high98%10

1-year return+95%10

3-year return+161%9

5-year return+161%8

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +161% over three years and +161% over five, ahead of 80% of the market.

It's up 95% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+7%), over three months (+9%) and so far this year (+111%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Hinge Health. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

HNGEHinge Health

Revenue FY25$588M

GROWTH RATING↗

VERY STRONG88 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGRna–

Revenue, next 1Y+46%10

Revenue, next 3Y, CAGR+31%10

Revenue, next 5Y, CAGR+28%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+28%8

EPS growth, FY28E+40%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 88% of companies worldwide.

Revenue is set to grow 31%/yr over the next 3 years, ahead of most of the market.10/10

Revenue held flat over the last 3 years and is set to grow 31%/yr from here.

The runway holds up: revenue is set to grow 28%/yr over five years.10/10

Earnings are set to grow in step with sales (EPS about 28%/yr vs revenue 31%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG98 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+7%10

3-month return+9%8

YTD return+111%10

MID & LONG-TERM▾SCORE

% of 52-week high98%10

1-year return+95%10

3-year return+161%9

5-year return+161%8

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +161% over three years and +161% over five, ahead of 80% of the market.

It's up 95% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+7%), over three months (+9%) and so far this year (+111%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Hinge Health. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community